Multiple Manufacturers

LEUKINE

Manufacturer:

Multiple Manufacturers

Leukine HCPCS:

J2820

HCPCS Code Descriptor:

Injection, sargramostim (gm-csf), 50 mcg

Category:

J Code

Leukine NDCs:

71837-5843-05, 00024-5843-05

Primary Type:

Oncology Colony Stimulating Factor

Generic/Specialty Status:

Multi-Source

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00024-5843-05

About Leukine:

LEUKINE is an Oncology Colony Stimulating Factor drug manufactured by Sanofi and administered via the Injection route of administration. The J Code: J2820 is aligned to the drug LEUKINE.

ACCESS PRICING AND MORE BY REGISTERING

J2820 Added Date:

January 1, 1982

J2820 Effective Date:

January 1, 1998

J2820 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Leukine billing and coding information.
Leukine patient assistance information can be found through LEUKINEDIRECT product access services at the URL: https://www.leukine.com/patient-assistance/
LEUKINE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for LEUKINE. Please check back in a few weeks.